Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 August 2024 | Story Valentino Ndaba | Photo Supplied
UFS Womens Day 2024 - Read More
Celebrating Women's Month at UFS: Empowering women in academia through mentorship, support, and excellence.

Improving the equity profile of the professoriate, increasing the intellectual diversity of staff, and aspiring for gender parity in all its leadership positions form an integral part of what the University of the Free State (UFS) stands for. This is also in support of Vision 130, the UFS’ bold, comprehensive strategy to renew and reimagine itself for 2034, when it will celebrate its 130th anniversary. 

Diversity and inclusivity are hallmarks of our culture and our commitment to social justice. As such, we believe there should be no limit to the career aspirations of women in academia – a belief we underscore by providing them with ample opportunities, skills development, and support to realise their ambitions, while simultaneously ensuring that they have maximum societal impact within their areas of expertise.

Passionate, talented, and innovative women have been instrumental in contributing towards excellence in teaching and learning, engaged scholarship, and research endeavours at the UFS. A prime example of this is the fact that the majority of our SARChI Research Chairs are currently being held by female researchers.

To address areas of underrepresentation of women in senior academic and leadership positions within the university, a Working Group on Gender Parity in Academic Leadership was established, with the critical mandate of driving attitudinal shifts, advocating for changes where necessary, and highlighting barriers to women's advancement. Supplementing this, we have specific and dedicated development and mentorship programmes aimed at advancing the careers of women academics.

Transformation of the Professoriate Mentoring Programme

The university’s commitment to academic excellence, impact, and transformation has transpired in a set of deliberate, comprehensive mentorship interventions to rectify gender and racial imbalances in a responsible and effective way. 

The UFS launched its Transformation of the Professoriate Mentoring Programme five years ago with the aim of developing and supporting emerging scholars on the cusp of promotion to senior academic positions. It focuses on the holistic development of the skills and attributes of emerging scholars in the core functions of teaching and learning, research, community engagement, and academic leadership in preparation for their roles as future professors and academic leaders. Currently, the overwhelming majority of participants are women.

The programme has evolved into different branches, each with a distinct focus area: 

Women Influencing Scholarship and Education (WISE)

This newly launched programme aims to nurture academic leaders while also supporting women's progression within the academic ranks. In the process, structural barriers, attitudinal issues, and behavioural impediments hindering the career progression of women in academia are addressed and overcome.

The programme is targeted at mid-career academic women, with the aim of increasing the number of women academics eligible for academic leadership and senior management positions and accelerating career progression towards professoriate levels. Among the opportunities that are unlocked are the development of personal branding, digital presence enhancement, as well as communication and presentation skills. 

Participants are also guided on emerging digital trends, and assisted in obtaining funding, project development, collaborative projects, and community building.

Women academics are encouraged to invest in themselves, and in the process, increased research productivity, impact, and visibility are achieved, and sustainable academic careers are advanced. 

Future Professoriate group

This is a tailormade development programme characterised by individual mentoring discussions with multiple mentors, quarterly group meetings, writing retreats, monthly writing spaces, and group meetings with specific discussion topics, as well as a variety of training and support activities aimed at strengthening scholarly and leadership competencies. Academics who have completed their three-year fellowship in this group proceed to serve as alumni mentors for new candidates in the programme.

• Emerging Scholar Accelerator group (ESAP)

This programme targets promising young academics in an even earlier stage of their careers, preparing them for entry into the Future Professoriate Group. Some of the activities of the two programmes are integrated to provide opportunities for colleagues from different departments and faculties to interact and benefit from the experience and competencies of the cohort. Individual career plans are drafted to monitor the progress of candidates towards different milestones, such as National Research Foundation (NRF) rating, receiving prestigious international fellowships, graduating PhD candidates, and being recognised for excellence in leadership, community engagement, and teaching and learning.

• Researcher Excellence Accelerator Programme (REAP) 

The REAP programme seeks to understand the unique needs of early career researchers and to create supportive clusters as an effective strategy to help navigate their careers through what can be a complex and daunting academic environment. Senior academics guide junior colleagues to the successful completion of their PhDs, enabling them to establish themselves as researchers with a strong research profile through access to mentors, training, peer support, and academic networks, all tailored to the specific needs of the researcher.

Positive results yielded

Half a decade of structured, intensive mentorship in the Transforming of the Professoriate Mentoring Programme has yielded positive results:

• 110 candidates have benefited from the programme over the past five years and are almost without exception performing extremely well.
• 77% of the 2023 cohort of the ESAP programme were women. 
• Success rate of the first Future Professoriate Group (measured by promotions) stands at 73%.
• Around 70% of the selected candidates in the different programmes are black South African and African foreign-born candidates, going a long way towards addressing historic imbalances in racial equity. 
• During the last four years, candidates of the programme published a total of 315 academic articles, as well as 30 books. 
• Candidates report increased international collaboration, advances in NRF ratings, and are recipients of a total of 22 prestigious research grants.
• Participants’ feedback bears evidence of not only scholarly development, but also an increased sense of engagement with the university community, and a strengthening of collaboration among junior and senior colleagues. 

Paying it forward

As candidates who have successfully completed mentorship and development programmes, in turn, become mentors to new entrants, these successes promise to grow exponentially over the coming years. The Transformation of the Professoriate Mentoring Programme aims to further strengthen its mentoring and capacity-building programmes, while simultaneously entrenching broader institutional mentoring practices to lure and retain excellent academics in all faculties and departments. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept